计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| D125841-5mg |
5mg |
现货 ![]() |
| |
| D125841-10mg |
10mg |
现货 ![]() |
| |
| D125841-50mg |
50mg |
现货 ![]() |
| |
| D125841-250mg |
250mg |
现货 ![]() |
| |
| D125841-1g |
1g |
现货 ![]() |
|
| 别名 | 达芦那韦 | 地瑞那韦 |
|---|---|
| 英文别名 | AIDS073035 | s5250 | NCGC00168773-01 | BCP0726000058 | BDBM8125 | Darunavirum [INN-Latin] | HSDB 7788 | 2ien | Darunavir [USAN:INN:BAN] | 2f8g | 4ll3 | CJBJHOAVZSMMDJ-HEXNFIEUSA-N | (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobuty |
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | Darunavir |
| 生化机理 | 高效的HIV蛋白酶抑制剂(IC50 = 3-6 nM,取决于实验室HIV-1株)。在感染了临床HIV-1菌株的细胞中显示活性,该菌株对其他蛋白酶抑制剂具有抗性。产品仅用于生物医学研究。不用于人类或兽医用途。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 人体免疫缺陷病毒 1 型蛋白酶抑制剂 |
| 产品介绍 |
HIV-1 antiviral structurally similar to amprenavir. Second generation HIV-1-protease inhibitor.HIV蛋白酶抑制剂。 An antiviral agent HIV-1 antiviral structurally similar to amprenavir. Second generation HIV-1-protease inhibitor. |
| 纯度 | ≥98% |
| ALogP | 2.9 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504757858 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate |
| INCHI | 1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1 |
| InChi Key | CJBJHOAVZSMMDJ-HEXNFIEUSA-N |
| Smiles | CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N |
| Isomeric SMILES | CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N |
| 分子量 | 547.66 |
| Reaxy-Rn | 22907710 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=22907710&ln= |
| 溶解性 | 溶于DMSO, 最高浓度 (mg/mL): 54.77, 最高浓度(mM): 100 |
|---|---|
| 熔点 | 74-76°C |
| 分子量 | 547.700 g/mol |
| XLogP3 | 2.900 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 9 |
| 可旋转键计数Rotatable Bond Count | 12 |
| 精确质量Exact Mass | 547.235 Da |
| 单同位素质量Monoisotopic Mass | 547.235 Da |
| 拓扑极表面积Topological Polar Surface Area | 149.000 Ų |
| 重原子数Heavy Atom Count | 38 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 853.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 5 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| WGK Germany | 3 |
|---|
| 1. Koh Y, Nakata H, Maeda K, Ogata H, Bilcer G, Devasamudram T, Kincaid JF, Boross P, Wang YF, Tie Y et al.. (2003) Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro.. Antimicrob Agents Chemother, 47 (10): (3123-9). [PMID:14506019] |
| 2. Chen J, Xia L, Liu L, Xu Q, Ling Y, Huang D, Huang W, Song S, Xu S, Shen Y et al.. (2020) Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19.. Open Forum Infect Dis, 7 (7): (ofaa241). [PMID:32671131] |
| 3. Fenglun Zhao, Zheng Xiang, Junping Han, Jie Pan, Yuchen Qu, Kai Fan, Zhiqiang Wu, Delai Xu, Yunli Yu, Zhu Shen, Cunjin Su. (2024) Simultaneous quantification of nirmatrelvir/ritonavir in human serum by LC–HRMS. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 237 (115796). [PMID:37839266] [10.1016/j.jpba.2023.115796] |
| 4. Dai Tianming, Wang Min, Wang Pengzhen, Dai Libing, Dai Renke, Meng Qingqi. (2021) Inhibition effects of eight anti-coronavirus drugs on glycosides metabolism and glycosidases in human gut microflora. PHARMAZIE, 76 (5): (195-201). [PMID:33964992] [10.1691/ph.2021.01005] |